{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:54:41Z","timestamp":1787630081610,"version":"build-2736575974"},"reference-count":43,"publisher":"Tech Science Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.060573","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:15:46Z","timestamp":1737346546000},"page":"1001-1005","source":"Crossref","is-referenced-by-count":7,"title":["The SS18-SSX fusion oncoprotein: Friend and foe in targeted therapy for synovial sarcoma"],"prefix":"10.32604","volume":"33","author":[{"given":"GAVIN M.","family":"ANCHONDO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KYRA","family":"PARKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEXIS","family":"BRUCE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELIZABETH","family":"CORTEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LE","family":"SU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1200\/JCO.21.01628","article-title":"Synovial sarcoma in children, adolescents, and young adults: a report from the Children\u2019s Oncology GroUp ARST0332 study","volume":"39","author":"Venkatramani","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/stem.452","article-title":"Synovial sarcoma is a stem cell malignancy","volume":"28","author":"Naka","year":"2010","journal-title":"Stem Cells"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2309499020936009","DOI":"10.1177\/2309499020936009","article-title":"Epidemiology, incidence, and survival of synovial sarcoma subtypes: SEER database analysis","volume":"28","author":"Aytekin","year":"2020","journal-title":"J Orthop Surg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1369\/00221554231184287","article-title":"SS18-SSX antibody: a useful tool to save time and reduce costs in synovial sarcoma diagnosis. Proposal of a novel diagnostic algorithm","volume":"71","author":"Orlando","year":"2023","journal-title":"J Histochem Cytochem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7192347","DOI":"10.1155\/2020\/7192347","article-title":"Diagnostic value of TLE1 in synovial sarcoma: a systematic review and meta-analysis","volume":"2020","author":"El Beaino","year":"2020","journal-title":"Sarcoma"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/annonc\/mdi082","article-title":"Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital","volume":"16","author":"Spurrell","year":"2005","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/annonc\/mdq394","article-title":"Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors","volume":"22","author":"Krieg","year":"2011","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11864-021-00914-4","article-title":"The biology of synovial sarcoma: state-of-the-art and future perspectives","volume":"22","author":"Fiore","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101618","DOI":"10.1016\/j.esmoop.2023.101618","article-title":"Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies","volume":"8","author":"Blay","year":"2023","journal-title":"ESMO Open"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2016.02.002","article-title":"Outcome of chemotherapy in advanced synovial sarcoma patients: review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity","volume":"58","author":"Vlenterie","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/COC.0000000000000243","article-title":"Successful ifosfamide rechallenge in soft-tissue sarcoma","volume":"41","author":"Noujaim","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/cells13201695","article-title":"Genetic and molecular heterogeneity of synovial sarcoma and associated challenges in therapy","volume":"13","author":"Lesovaya","year":"2024","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2217\/fon-2022-0477","article-title":"Treatment patterns and outcomes in metastatic synovial sarcoma: a real-world study in the US oncology network","volume":"18","author":"Pokras","year":"2022","journal-title":"Future Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"189215","DOI":"10.1016\/j.bbcan.2024.189215","article-title":"Advances of SS18-SSX fusion gene in synovial sarcoma: emerging novel functions and therapeutic potentials","volume":"1879","author":"Ren","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.tig.2020.07.011","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies","volume":"36","author":"Centore","year":"2020","journal-title":"Trends Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/sj.onc.1202613","article-title":"SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex","volume":"18","author":"Soulez","year":"1999","journal-title":"Oncogene"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2164-13-189","article-title":"Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2","volume":"13","author":"Garcia","year":"2012","journal-title":"BMC Genomics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2012.01.010","article-title":"Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics","volume":"21","author":"Su","year":"2012","journal-title":"Cancer Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41591-020-01212-6","article-title":"Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma","volume":"27","author":"Jerby-Arnon","year":"2021","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13046-021-02150-y","article-title":"Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma","volume":"40","author":"Lanzi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41594-023-01096-3","article-title":"Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability","volume":"30","author":"Benabdallah","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ccell.2018.05.002","article-title":"The SS18-SSX fusion oncoprotein Hijacks BAF complex targeting and function to drive synovial sarcoma","volume":"33","author":"McBride","year":"2018","journal-title":"Cancer Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41594-020-0466-9","article-title":"The nucleosome acidic patch and H2A ubiquitination underlie mSWI\/SNF recruitment in synovial sarcoma","volume":"27","author":"McBride","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2007.01.016","article-title":"A conditional mouse model of synovial sarcoma: insights into a myogenic origin","volume":"11","author":"Haldar","year":"2007","journal-title":"Cancer Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1158\/2159-8290.CD-20-1219","article-title":"A role for SMARCB1 in synovial sarcomagenesis reveals that SS18-SSX induces canonical BAF destruction","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.7554\/eLife.41305","article-title":"Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma","volume":"7","author":"Brien","year":"2018","journal-title":"eLife"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"25239","DOI":"10.1038\/srep25239","article-title":"Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of synovial sarcoma in vitro","volume":"6","author":"Shen","year":"2016","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e0158888","DOI":"10.1371\/journal.pone.0158888","article-title":"Preclinical evidence of anti-tumor activity induced by EZH2 inhibition in human models of synovial sarcoma","volume":"11","author":"Kawano","year":"2016","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1479-5876-10-216","article-title":"Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)","volume":"10","author":"Changchien","year":"2012","journal-title":"J Transl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.17305\/bjbms.2017.1938","article-title":"Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis","volume":"17","author":"Yalcinkaya","year":"2017","journal-title":"Bosn J Basic Med Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"34384","DOI":"10.18632\/oncotarget.8882","article-title":"Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay","volume":"7","author":"Laporte","year":"2016","journal-title":"Oncotarget"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0169407","DOI":"10.1371\/journal.pone.0169407","article-title":"HDAC and proteasome inhibitors synergize to activate pro-apoptotic factors in synovial sarcoma","volume":"12","author":"Laporte","year":"2017","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.isci.2019.02.008","article-title":"HDAC2 regulates site-specific acetylation of MDM2 and its ubiquitination signaling in tumor suppression","volume":"13","author":"Patel","year":"2019","journal-title":"iScience"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1914291","DOI":"10.1080\/23723556.2021.1914291","article-title":"HDAC2 links ubiquitination to tumor suppression in synovial sarcoma","volume":"8","author":"Cooley","year":"2021","journal-title":"Mol Cell Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40291-020-00487-2","article-title":"Assessment of synergistic contribution of histone deacetylases in prognosis and therapeutic management of sarcoma","volume":"24","author":"Mastoraki","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdv033","article-title":"A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent\/metastatic sarcomas-NCIC-CTG IND 200dagger","volume":"26","author":"Chu","year":"2015","journal-title":"Ann Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1422452","DOI":"10.3389\/fcell.2024.1422452","article-title":"Combination of HDAC and FYN inhibitors in synovial sarcoma treatment","volume":"12","author":"Parker","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/cdd.2015.66","article-title":"Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity","volume":"23","author":"Zhang","year":"2016","journal-title":"Cell Death Differ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1074\/jbc.271.2.695","article-title":"Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation","volume":"271","author":"Hanke","year":"1996","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13048-021-00797-x","article-title":"Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors","volume":"14","author":"Crean-Tate","year":"2021","journal-title":"J Ovarian Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13048-023-01194-2","article-title":"LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer","volume":"16","author":"Dey","year":"2023","journal-title":"J Ovarian Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-023-03930-0","article-title":"FYN: emerging biological roles and potential therapeutic targets in cancer","volume":"21","author":"Peng","year":"2023","journal-title":"J Transl Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3892\/ol.2024.14658","article-title":"Role of Fyn expression in predicting the sensitivity to platinum\u2010based chemotherapy in patients with ovarian serous carcinoma","volume":"28","author":"Uchikura","year":"2024","journal-title":"Oncol Lett"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-5\/OncolRes-33-05-60573\/OncolRes-33-60573.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:08:48Z","timestamp":1763341728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n5\/60621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.060573","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}